To include your compound in the COVID-19 Resource Center, submit it here.

NPS drops 17% on Natpara vote

NPS Pharmaceuticals Inc. (NASDAQ:NPSP) lost $5.42 (17%) to $27.29 on Monday after FDA's Endocrinologic and Metabolic Drugs Advisory Committee

Read the full 194 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE